Batch of colorectal cancer drug recalled


A batch of a US-made intravenous drug used to treat a certain type of colorectal cancer has been ordered recalled by a local distributor due to a vial seal defect that may cause adverse health reactions. According to an Oct. 23 advisory issued by the Food and Drug Administration, panitumumab, branded as Vectibix (20mg/ml) concentrate,

Read more at : inquirer

Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.